CARERX CORP (CRRX.CA) Stock Fundamental Analysis
Canada - TSX:CRRX - CA14173C1059 - Common Stock
3.55 CAD
-0.01 (-0.28%)
CRRX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 17 industry peers in the Consumer Staples Distribution & Retail industry. CRRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CRRX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CRRX had negative earnings in the past year.
In the past year CRRX had a positive cash flow from operations.
CRRX had negative earnings in each of the past 5 years.
Each year in the past 5 years CRRX had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -0.83%, CRRX is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
The Return On Equity of CRRX (-2.09%) is worse than 76.47% of its industry peers.
CRRX has a worse Return On Invested Capital (3.79%) than 64.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRRX is below the industry average of 7.74%.
The last Return On Invested Capital (3.79%) for CRRX is above the 3 year average (3.05%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.83% | ||
| ROE | -2.09% | ||
| ROIC | 3.79% |
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
1.3 Margins
CRRX's Operating Margin of 2.33% is on the low side compared to the rest of the industry. CRRX is outperformed by 70.59% of its industry peers.
CRRX's Operating Margin has improved in the last couple of years.
The Gross Margin of CRRX (29.54%) is comparable to the rest of the industry.
CRRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 29.54% |
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRRX is destroying value.
Compared to 1 year ago, CRRX has more shares outstanding
The number of shares outstanding for CRRX has been increased compared to 5 years ago.
Compared to 1 year ago, CRRX has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.02, we must say that CRRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.02, CRRX is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
CRRX has a debt to FCF ratio of 3.62. This is a good value and a sign of high solvency as CRRX would need 3.62 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.62, CRRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.85 indicates that CRRX is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.85, CRRX is doing good in the industry, outperforming 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 3.62 | ||
| Altman-Z | 1.02 |
ROIC/WACC0.54
WACC7.08%
2.3 Liquidity
A Current Ratio of 1.08 indicates that CRRX should not have too much problems paying its short term obligations.
The Current ratio of CRRX (1.08) is worse than 82.35% of its industry peers.
A Quick Ratio of 0.78 indicates that CRRX may have some problems paying its short term obligations.
The Quick ratio of CRRX (0.78) is better than 76.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
CRRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.73%, which is quite impressive.
Looking at the last year, CRRX shows a decrease in Revenue. The Revenue has decreased by -0.16% in the last year.
Measured over the past years, CRRX shows a very strong growth in Revenue. The Revenue has been growing by 24.10% on average per year.
EPS 1Y (TTM)72.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.63%
3.2 Future
CRRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 76.49% yearly.
The Revenue is expected to grow by 5.78% on average over the next years.
EPS Next Y260.65%
EPS Next 2Y128.32%
EPS Next 3Y76.49%
EPS Next 5YN/A
Revenue Next Year1.78%
Revenue Next 2Y4.4%
Revenue Next 3Y5.78%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CRRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 15.78 indicates a correct valuation of CRRX.
CRRX's Price/Forward Earnings is on the same level as the industry average.
CRRX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRRX indicates a slightly more expensive valuation: CRRX is more expensive than 64.71% of the companies listed in the same industry.
CRRX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.89 | ||
| EV/EBITDA | 10.86 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRRX's earnings are expected to grow with 76.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y128.32%
EPS Next 3Y76.49%
5. Dividend
5.1 Amount
CRRX has a Yearly Dividend Yield of 2.25%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.59, CRRX pays a bit more dividend than its industry peers.
CRRX's Dividend Yield is comparable with the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
5.2 History
CRRX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y128.32%
EPS Next 3Y76.49%
TSX:CRRX (10/17/2025, 7:00:00 PM)
3.55
-0.01 (-0.28%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners53.73%
Inst Owner ChangeN/A
Ins Owners10.33%
Ins Owner ChangeN/A
Market Cap223.58M
Analysts81.67
Price Target4.37 (23.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.98%
Min EPS beat(2)-100%
Max EPS beat(2)-1.96%
EPS beat(4)0
Avg EPS beat(4)-164.25%
Min EPS beat(4)-296.08%
Max EPS beat(4)-1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.09%
Min Revenue beat(2)-3.67%
Max Revenue beat(2)-2.51%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.67%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-2.35%
Revenue beat(12)1
Avg Revenue beat(12)-2.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.89%
PT rev (1m)8.11%
PT rev (3m)13.21%
EPS NQ rev (1m)-51.22%
EPS NQ rev (3m)-51.22%
EPS NY rev (1m)-22.63%
EPS NY rev (3m)10.69%
Revenue NQ rev (1m)-3.71%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.78 | ||
| P/S | 0.61 | ||
| P/FCF | 9.89 | ||
| P/OCF | 7.03 | ||
| P/B | 2.57 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.86 |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.22
Fwd EY6.34%
FCF(TTM)0.36
FCFY10.12%
OCF(TTM)0.51
OCFY14.23%
SpS5.82
BVpS1.38
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.83% | ||
| ROE | -2.09% | ||
| ROCE | 5.27% | ||
| ROIC | 3.79% | ||
| ROICexc | 4.01% | ||
| ROICexgc | 11.71% | ||
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 29.54% | ||
| FCFM | 6.18% |
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)11.1%
ROICexgc(5y)N/A
ROCE(3y)4.24%
ROCE(5y)N/A
ROICexcg growth 3Y15.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.67%
ROICexc growth 5YN/A
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 3.62 | ||
| Debt/EBITDA | 2.7 | ||
| Cap/Depr | 48.72% | ||
| Cap/Sales | 2.51% | ||
| Interest Coverage | 2.01 | ||
| Cash Conversion | 116.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 1.02 |
F-Score7
WACC7.08%
ROIC/WACC0.54
Cap/Depr(3y)51.22%
Cap/Depr(5y)43.4%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y260.65%
EPS Next 2Y128.32%
EPS Next 3Y76.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.63%
Revenue Next Year1.78%
Revenue Next 2Y4.4%
Revenue Next 3Y5.78%
Revenue Next 5YN/A
EBIT growth 1Y-1.59%
EBIT growth 3Y15.72%
EBIT growth 5YN/A
EBIT Next Year371.2%
EBIT Next 3Y84.1%
EBIT Next 5YN/A
FCF growth 1Y-23.56%
FCF growth 3Y480.16%
FCF growth 5Y59.88%
OCF growth 1Y-16.1%
OCF growth 3Y73.54%
OCF growth 5Y42.97%